Cargando…

Update on the strategy for intravenous fluid treatment in acute pancreatitis

Fluid therapy/resuscitation is mandatory in acute pancreatitis due to the pathophysiology of fluid loss as a consequence of the inflammatory process. For many years, without clear evidence, early and aggressive fluid resuscitation with crystalloid solutions (normal saline solution or Ringer lactate...

Descripción completa

Detalles Bibliográficos
Autores principales: Yaowmaneerat, Thanapon, Sirinawasatien, Apichet
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10167805/
https://www.ncbi.nlm.nih.gov/pubmed/37179816
http://dx.doi.org/10.4292/wjgpt.v14.i3.22
_version_ 1785038741395472384
author Yaowmaneerat, Thanapon
Sirinawasatien, Apichet
author_facet Yaowmaneerat, Thanapon
Sirinawasatien, Apichet
author_sort Yaowmaneerat, Thanapon
collection PubMed
description Fluid therapy/resuscitation is mandatory in acute pancreatitis due to the pathophysiology of fluid loss as a consequence of the inflammatory process. For many years, without clear evidence, early and aggressive fluid resuscitation with crystalloid solutions (normal saline solution or Ringer lactate solution) was recommended. Recently, many randomized control trials and meta-analyses on fluid therapy have revealed that high fluid rate infusion is associated with increased mortality and severe adverse events compared to those resulting from moderate fluid rates, and this has triggered a paradigm shift in fluid management strategies. Meanwhile, there is evidence to show that Ringer lactate solution is superior to normal saline solutions in this context. The purpose of this review is to provide an update on the strategies for intravenous fluid treatment in acute pancreatitis, including the type, optimal amount, rate of infusion, and monitoring guides. Recommendations from recent guidelines are critically evaluated for this review in order to reach the authors' recommendations based on the available evidence.
format Online
Article
Text
id pubmed-10167805
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Baishideng Publishing Group Inc
record_format MEDLINE/PubMed
spelling pubmed-101678052023-05-10 Update on the strategy for intravenous fluid treatment in acute pancreatitis Yaowmaneerat, Thanapon Sirinawasatien, Apichet World J Gastrointest Pharmacol Ther Minireviews Fluid therapy/resuscitation is mandatory in acute pancreatitis due to the pathophysiology of fluid loss as a consequence of the inflammatory process. For many years, without clear evidence, early and aggressive fluid resuscitation with crystalloid solutions (normal saline solution or Ringer lactate solution) was recommended. Recently, many randomized control trials and meta-analyses on fluid therapy have revealed that high fluid rate infusion is associated with increased mortality and severe adverse events compared to those resulting from moderate fluid rates, and this has triggered a paradigm shift in fluid management strategies. Meanwhile, there is evidence to show that Ringer lactate solution is superior to normal saline solutions in this context. The purpose of this review is to provide an update on the strategies for intravenous fluid treatment in acute pancreatitis, including the type, optimal amount, rate of infusion, and monitoring guides. Recommendations from recent guidelines are critically evaluated for this review in order to reach the authors' recommendations based on the available evidence. Baishideng Publishing Group Inc 2023-05-05 2023-05-05 /pmc/articles/PMC10167805/ /pubmed/37179816 http://dx.doi.org/10.4292/wjgpt.v14.i3.22 Text en ©The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved. https://creativecommons.org/licenses/by-nc/4.0/This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial.
spellingShingle Minireviews
Yaowmaneerat, Thanapon
Sirinawasatien, Apichet
Update on the strategy for intravenous fluid treatment in acute pancreatitis
title Update on the strategy for intravenous fluid treatment in acute pancreatitis
title_full Update on the strategy for intravenous fluid treatment in acute pancreatitis
title_fullStr Update on the strategy for intravenous fluid treatment in acute pancreatitis
title_full_unstemmed Update on the strategy for intravenous fluid treatment in acute pancreatitis
title_short Update on the strategy for intravenous fluid treatment in acute pancreatitis
title_sort update on the strategy for intravenous fluid treatment in acute pancreatitis
topic Minireviews
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10167805/
https://www.ncbi.nlm.nih.gov/pubmed/37179816
http://dx.doi.org/10.4292/wjgpt.v14.i3.22
work_keys_str_mv AT yaowmaneeratthanapon updateonthestrategyforintravenousfluidtreatmentinacutepancreatitis
AT sirinawasatienapichet updateonthestrategyforintravenousfluidtreatmentinacutepancreatitis